TriMas (NASDAQ:TRS) Hits New 1-Year High – Still a Buy?

TriMas Corporation (NASDAQ:TRS) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $42.00 and last traded at $38.00, with a volume of 50602 shares trading hands. The stock had previously closed at $36.85.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Zacks Research lowered TriMas from a “strong-buy” rating to a “hold” rating in a research note on Thursday, December 11th. KeyCorp reaffirmed an “overweight” rating on shares of TriMas in a research note on Thursday. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a research note on Monday, December 29th. BWS Financial reaffirmed a “buy” rating and issued a $45.00 target price on shares of TriMas in a research note on Friday, December 5th. Finally, Wall Street Zen cut shares of TriMas from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.50.

TriMas Price Performance

The stock has a market capitalization of $1.59 billion, a P/E ratio of 36.03 and a beta of 0.57. The firm has a fifty day moving average price of $35.47 and a two-hundred day moving average price of $35.95. The company has a quick ratio of 1.42, a current ratio of 2.68 and a debt-to-equity ratio of 0.56.

TriMas (NASDAQ:TRS) last released its quarterly earnings data on Thursday, February 26th. The industrial products company reported $0.40 EPS for the quarter, missing the consensus estimate of $0.41 by ($0.01). The business had revenue of $155.49 million during the quarter, compared to the consensus estimate of $192.96 million. TriMas had a return on equity of 12.39% and a net margin of 4.35%.TriMas’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.43 earnings per share. On average, analysts expect that TriMas Corporation will post 1.69 EPS for the current year.

TriMas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 27th will be paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Friday, February 27th. TriMas’s dividend payout ratio (DPR) is 14.81%.

Institutional Investors Weigh In On TriMas

A number of large investors have recently made changes to their positions in the company. Los Angeles Capital Management LLC purchased a new position in shares of TriMas in the fourth quarter worth approximately $29,000. Covestor Ltd raised its position in TriMas by 20,525.0% in the fourth quarter. Covestor Ltd now owns 825 shares of the industrial products company’s stock worth $29,000 after acquiring an additional 821 shares during the period. Quarry LP purchased a new position in shares of TriMas during the 3rd quarter worth $36,000. Ball & Co Wealth Management Inc. bought a new stake in shares of TriMas during the 4th quarter valued at $35,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of TriMas in the 3rd quarter worth $48,000. 99.42% of the stock is currently owned by institutional investors.

TriMas Company Profile

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.